Literature DB >> 6376655

Importance of host factors in human salmonellosis caused by multiresistant strains of Salmonella.

L W Riley, M L Cohen, J E Seals, M J Blaser, K A Birkness, N T Hargrett, S M Martin, R A Feldman.   

Abstract

Antimicrobial resistance patterns of Salmonella isolates from persons in randomly selected urban and rural counties in the United States were examined along with clinical and epidemiological characteristics of the host. Multiresistant strains, isolated from 66 (12.2%) of 542 persons evaluated, were associated with five of 20 variables in univariate analyses: serotype heidelberg, host of Hispanic origin, host exposure to penicillins within four weeks before stool culture, age greater than or equal to 60 years, and regular antacid use. By multiple linear regression, the first three variables were each significantly associated with infections due to multiresistant Salmonella. One or more of the last three variables, thought to be host factors that may promote disease, were present for persons yielding 38% of multiresistant strains but only 12% of sensitive strains (P less than .001). The relatively large proportion of multiresistant Salmonella among isolates from persons with these risk factors suggests that to cause disease, resistant organisms are more dependent than are sensitive organisms on host characteristics.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6376655     DOI: 10.1093/infdis/149.6.878

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

Review 1.  Molecular basis of the interaction of Salmonella with the intestinal mucosa.

Authors:  K H Darwin; V L Miller
Journal:  Clin Microbiol Rev       Date:  1999-07       Impact factor: 26.132

2.  Comparison of plasmid profiles, phage types, and antimicrobial resistance patterns of Salmonella enteritidis isolates in the United States.

Authors:  D C Rodrigue; D N Cameron; N D Puhr; F W Brenner; M E St Louis; I K Wachsmuth; R V Tauxe
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

3.  Antimicrobial resistance among invasive nontyphoidal Salmonella enterica isolates in the United States: National Antimicrobial Resistance Monitoring System, 1996 to 2007.

Authors:  John A Crump; Felicita M Medalla; Kevin W Joyce; Amy L Krueger; R Michael Hoekstra; Jean M Whichard; Ezra J Barzilay
Journal:  Antimicrob Agents Chemother       Date:  2011-01-03       Impact factor: 5.191

4.  Impact of age and drug resistance on mortality in typhoid fever.

Authors:  Z A Bhutta
Journal:  Arch Dis Child       Date:  1996-09       Impact factor: 3.791

Review 5.  Helicobacter and salmonella persistent infection strategies.

Authors:  Denise M Monack
Journal:  Cold Spring Harb Perspect Med       Date:  2013-12-01       Impact factor: 6.915

6.  Host transmission of Salmonella enterica serovar Typhimurium is controlled by virulence factors and indigenous intestinal microbiota.

Authors:  Trevor D Lawley; Donna M Bouley; Yana E Hoy; Christine Gerke; David A Relman; Denise M Monack
Journal:  Infect Immun       Date:  2007-10-29       Impact factor: 3.441

7.  Drug resistance and biochemical characteristics of Salmonella from turkeys.

Authors:  C Poppe; J J Kolar; W H Demczuk; J E Harris
Journal:  Can J Vet Res       Date:  1995-10       Impact factor: 1.310

8.  Antibiotic use among children in an urban Brazilian slum: a risk factor for diarrhea?

Authors:  J B Schorling; M A De Souza; R L Guerrant
Journal:  Am J Public Health       Date:  1991-01       Impact factor: 9.308

9.  Selective antimicrobial modulation of the intestinal tract by norfloxacin in human volunteers and in gnotobiotic mice associated with a human fecal flora.

Authors:  S Pecquet; A Andremont; C Tancrède
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191

10.  Hospitalization and antimicrobial resistance in Salmonella outbreaks, 1984-2002.

Authors:  Jay K Varma; Katherine D Greene; Jessa Ovitt; Timothy J Barrett; Felicita Medalla; Frederick J Angulo
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.